We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Not sure what's been going on with this today. As you imply Terry, it's easy to manipulate an SP in this kind of scenario, so probably nothing in it.
I took some hope from the recent Report. Notably that the cash runway seems to be extended well into 2024. With so many balls still in the air, in terms of ongoing research collaborations, there has to be potential that at least one of them will lead to something and that extra time could be useful. Nor are they small things: if RENE's exosomes really do provide an effective drug delivery mechanism, that remains very exciting. And who knows what Fosun's Trials will come up with? I hope that Sajy is right in his confidence on this. Like many long-term investors here, my holding's no longer worth much, so I think I would be crazy to give up now! GLA.
I'd wait for a few sellers first and a dip to add more if I was you
Trying to get another 50K but had to put a trade plan in at 6.6. Not sure if it will get filled.
And NT to buy at 6.5p again not even 5000 available
All the mm's are stacking nobody wants to make a play, 6 of them have moved to 6p bid leaving 1 offering 6.5p...zzzz
Once ‘ topping up’ was a frequently used term on this board, only to be replaced by ‘averaging down’. As Sajy implies, if there’s sufficient rebound it enhances gains, if there isn’t, averaging down only magnifies losses. Hopefully, although not guaranteed, it’s the former.
Been NT almost all morning, brief opening of limits at 6.1p but not even 5000 available at 6.3p now online
Wanted another 100K shares this morning but was NT. Had to buy in smaller amounts to get filled. Have added substantially over the last few days. Even after averaging down, currently underwater here but have brought my average down. I am one of the very few that still believes Rene will come good.
Expecting update on in vivo data in about 6 weeks and then enter licensing deal discussions with partner. Need that first licensing deal and then sentiment will change.
Note a lot of massive trades this week, clearly a seller crossing with a buyer. I tried to buy this afternoon and it was NT so I had to pay 6p when 5.9p. So at the moment it's a overhang clearing play so might have a bounce spike, of course going forward they might raise money but atm there is a squeeze
Another Woodford success.
Thank you Laz for the local insight. Yep, the exec blew the best part of 150m of other people’s money; every development was linear and every phase test late. It seems Mr Ross saw that albeit he’s left with pocket change to make a difference. Will others bail him out or instead reap the benefits of a liquidator’s fire sale? If I was on the other side of the fence the latter may sound attractive, but as I’ve only the cuff button of the shirt I’ve lost left it’s in many senses academic although nonetheless entertaining.
Awful company and feel genuinely sorry for long term holders. Warning signs were there - the COO and some of the scientists failed massively at GE Healthcare, delivered nothing and took big redundancy packages. We had a trip to Cardiff escape rooms where the COO and Senior Scientist led a team that had to be rescued by management after 2 hours. Aim was always to demonstrate the right corporate behaviours to cover up for idiocy. Some also happy to take a salary from Celixr. Terrible people with no morals. Managed to waste years at GE developing awful products that were never going to launch, but had no spine to say anything. Got rid of any outsiders whilst protecting lab technicians on high salaries. Then repeat the trick elsewhere. Low life scumbags.
Twenty plus years I have held this share I stupidly thought my kids would prosper how wrong was I, never no sign of a divy, to many chiefs and no indians they need to pull a white rabbit out of the hat, not fresh air.
You should check your maths old man, Iain's holdings would have cost him less than £50k
They still have time, but the SP tells you that the clock is ticking. Everyone knows that, including Iain and the rest of the team. I agree, some more inside buying will probably be required for any of us to follow suit. I bought in here as a bit of a punt after Iain joined, and am willing to see what happens, with my eyes fully open. Expectations suitable for the risk profile too. Would probably take a few more if he did another 100K (or more) buy. Buttons at this price! Good weekend all.
Just added up the cost of Iain Ross’s holdings and he’s spent almost £90k on them. However, considering how much the SP has fallen recently, if he’s not tempted to buy a lot more at these prices, then I don’t hold out much hope for the company. Just one deal would transform sentiment and the latest results still suggests that deals will follow over the next year. I do hope so - I’ve lost a shedload!
Rene has no news it needs to change it,s name to bag of crap it will not last another year.
Didn't catch the update today.... obviously nothing of note hence the drop....I'm 97% down so may as well hang on for a miracle.....
Iain's purchases amount to less than £50k, which is nominal in the scheme of things
I guess, given Thursday is happening Rene is still deemed a going concern. If correct that seems to indicate the erstwhile Mr Ross is not going to liquidate or cease trading, certainly anytime soon, which may even suggest us budding alchemists, astrologers, and delusionists will be in work for a while longer too - yeah.
Fair enough. Absolutely not one for widows or orphans! And I also agree pretty much last chance saloon here. Have to disagree on what a nominal holding is though, because IMO what Iain purchased here is not really beer money. A few other employees also took a few too, albeit on a smaller scale than Iain of course.
Death or glory? Not long to find out! GLA
I've been in with ETX since 2.75p and C4XD since the lofty heights of 40p, although average is now 24p. I agree that the jury is still out with them but the difference is they have no issue raising funds - when they do, it's at nearly zero discount to the SP. Ali Mortazavi and Clive Dix are longstanding and very well respected figureheads who have a lot of skin in the game (Iain Ross has only a nominal holding in RENE). I still believe both companies will be bought out by big pharma in due course.
RENE are very much in the last chance saloon, and it's a binary play with a very short runway. I just think if it was a commercially attractive product, they would have secured agreements by now but this week will reveal more. Good luck to all remaining holders, but I no longer have the faith here
Well, very similar if you were a holder from the beginning in all of them, from the various charts! Not saying C4 or ETX (which I did not mention, but do vaguely remember glancing at a few years ago, now you have cited it) are going the same way as 4D, but the jury will presumably be out on those until they are profitable. Do like the look of the free float on ETX though, now I have had a look. Market caps and shares in issue in both are not comparable to RENE though, who under Iain is now (I think) well managed and he is personally invested too. I assume he thinks they have commercially attractive products to have taken the job, let alone purchased a respectable amount of shares from his own pocket as well. But the clock is ticking and all holders here will know that the window of opportunity to prove commercial viability is small. Hence the m/cap today.
All of this kind of proves my point though - the time, capital investment and opportunity cost in this space does not look pretty. Unless you bought and sold the bubbles, which I did in a couple, but made the mistake of investing, rather than trading these types. Will this have longer term ramifications for investment in this space in future, was more the point I have been pondering. Perhaps the big boys will have to go back to doing all their own R&D, rather than snapping up the odd small cap drug discovery outfit that finds success?
I don't think you can put C4XD or ETX in the same boat as RENE and 4D!!!
I take on board your point about the performance of some boards (I have been in a shareholder in all the aforementioned) but those are the risks you take when you invest. 4D got carried away with easy finance environment which then ran out. I'm not convinced RENE actually have a commercially attractive product unfortunately. I have far greater hope for ETX and C4XD, both of which are well managed companies, with directors who are personally invested
Spot on, Porky, although I have been impressed with Iain so far. Took a small punt off the back of his joining. Whether he can turn this one around, remains to be seen. Unlike so many AIM BODs though, he actually has a track record of success - and has put some of his own money in too. Still a high risk venture and I am under no illusions as to binary nature of this one.
Longer term, it will be interesting to see what, if any, impact the historically inept and greedy BOD activity, spanning so many of these types of outfits, will have on the approach to investing in the small cap bio field.
For me, I would not touch this area again in the small cap world. I hold here and a larger amount over at Evgen pharma, but IMO the risk/reward is simply unattractive now, so am not looking at any others. In the past, I had considered a few others like VAL and C4DX. I take a cursory glance over there now and again, but not remotely tempted! It does not help with the lack of consequences for failure and/or fraud that is so common on AIM it seems. Take 4D, which we both had the misfortune of being in. None of those directors should ever be allowed to hold a similar company position again IMO. They should also be investigated, to ensure it was 'only' their personal commercial uselessness that led to that outcome over there. Long jail terms and financial ruin, if otherwise. But we all know how very rare such things are, so AIM will remain a cesspit. Anyway, in danger of turning this into a rant now :) The sun is shining and life is too short! GLA.